CPT1A expression is increased in various cancers, including prostate, ovarian, glioblastoma, lymphoma, breast, gastric, and colon cancers [18]; however, it is hard to discern CPT1A expression and activity in the hypoxic regions of the tumor using the available clinical samples. This evidence concerns the gene CPT1A and lymphoma.